Pediatric Onco-Hematology Clinic, University Hospital Padova, Padova, Italy.
Leukemia. 2012 Jun;26(6):1375-82. doi: 10.1038/leu.2011.367. Epub 2012 Jan 6.
Understanding the mechanisms that control stress-induced apoptosis is critical to explain how tumours respond to treatment, as cancer cells frequently escape drug toxicity by regulating stress response through heat shock protein (HSP) expression. The overexpression of Hsp72, in particular, results in increased incidence of cell transformation, and correlates with poor prognosis in a wide range of cancers. We have shown that Hsp72 assists folding of oncogenic NPM-ALK kinase in anaplastic large-cell lymphomas (ALCLs), but its role in the maintenance of the malignant phenotype remains uncertain. Therefore, we assessed Hsp72 expression in ALCLs, investigating more in detail the mechanisms that regulate its status and activity. We found that Hsp72 is unique among the HSPs involved in tumourigenesis to be overexpressed in ALK(+) tumours and cell lines and to be induced by stress. Different from other HSPs, Hsp72 prevents cell injury, Bax activation and death by apoptosis in ALK(+) cells, acting both upstream and downstream of mitochondria. Conversely, Hsp72 is underexpressed in ALK(-) ALCL cells, and it is unable to protect cells from apoptosis under stress. Moreover, when Hsp72 expression is reduced following NPM-ALK inhibition, lymphoma cells undergo apoptosis, demonstrating the importance of Hsp72 in regulating ALCL stress response and drug sensitivity.
了解控制应激诱导细胞凋亡的机制对于解释肿瘤如何对治疗产生反应至关重要,因为癌细胞经常通过调节热休克蛋白(HSP)表达来逃避药物毒性。特别是 Hsp72 的过表达导致细胞转化的发生率增加,并与广泛的癌症中的预后不良相关。我们已经表明,Hsp72 有助于在间变性大细胞淋巴瘤(ALCL)中折叠致癌 NPM-ALK 激酶,但它在维持恶性表型中的作用仍不确定。因此,我们评估了 ALCL 中的 Hsp72 表达,更详细地研究了调节其状态和活性的机制。我们发现,Hsp72 在参与肿瘤发生的 HSP 中是独特的,在 ALK(+)肿瘤和细胞系中过表达,并受到应激的诱导。与其他 HSP 不同,Hsp72 可防止 ALK(+)细胞中的细胞损伤、Bax 激活和细胞凋亡,作用于线粒体的上游和下游。相反,Hsp72 在 ALK(-)ALCL 细胞中表达不足,并且在应激下无法保护细胞免受凋亡。此外,当 NPM-ALK 抑制后 Hsp72 表达减少时,淋巴瘤细胞发生凋亡,这表明 Hsp72 在调节 ALCL 应激反应和药物敏感性方面的重要性。